Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020192904 - 2-(1,2,3-TRIAZO-4-YL)-PYRROLE DERIVATIVES HAVING IONOPHORIC ACTIVITY

Publication Number WO/2020/192904
Publication Date 01.10.2020
International Application No. PCT/EP2019/057696
International Filing Date 27.03.2019
IPC
C07D 403/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/167
02containing two hetero rings
04directly linked by a ring-member-to-ring- member bond
A61P 11/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
CPC
A61P 11/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
C07D 403/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
403Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
02containing two hetero rings
04directly linked by a ring-member-to-ring-member bond
Applicants
  • UNIVERSIDAD DE BURGOS [ES]/[ES]
  • CONSIGLIO NAZIONALE DELLE RICERCHE - CNR [IT]/[IT]
  • IGG - IRCCS ISTITUTO GIANNINA GASLINI [IT]/[IT]
Inventors
  • QUESADA, Roberto
  • MORAN, Oscar
  • CACI, Emanuela
Agents
  • IGARTUA IRIZAR, Ismael
Priority Data
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) 2-(1,2,3-TRIAZO-4-YL)-PYRROLE DERIVATIVES HAVING IONOPHORIC ACTIVITY
(FR) DÉRIVÉS DE 2-(1,2,3-TRIAZO-4-YL)-PYRROLE AYANT UNE ACTIVITÉ IONOPHORIQUE
Abstract
(EN)
The invention relates to a compound of formula (I), a pharmaceutical composition comprising the compound, the compound or the pharmaceutical composition for use as a medicament and for the use in the treatment and/or prevention of diseases derived from abnormal anion transport at a cellular level and a method for obtaining the compound.
(FR)
L'invention concerne un composé de formule (I), une composition pharmaceutique comprenant le composé, le composé ou la composition pharmaceutique étant destiné(e) pour une utilisation en tant que médicament et pour une utilisation dans le traitement et/ou la prévention de maladies dérivées d'un transport d'anions anormal à un niveau cellulaire et un procédé d'obtention du composé.
Latest bibliographic data on file with the International Bureau